Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Journal of Thrombosis and Thrombolysis
Literature
1.
Bauduer F, Feingold J, Lacombe D (2005) The Basques: review of population genetics and mendelian disorders. Hum Biol 77:609–627CrossRef
2.
Bauduer F, Zivelin A, Ducout L et al (2004) The prevalence of factor V G1691A in French Basques, but not of prothrombin G20210A and methylene tetrahydrofolate reductase C677T, is remarkably low. J Thromb Haemost 2:361–362CrossRefPubMed
3.
Zivelin A, Bauduer F, Ducout L et al (2002) Factor XI deficiency in Basques is predominantly caused by an ancestral C38R mutation in the factor XI gene. Blood 99:2448–2454CrossRefPubMed
4.
Sakata T, Okamoto A, Mannami T et al (2004) Prevalence of protein S deficiency in the Japanese general population: the Suita study. J Thromb Haemost 2:1012–1013CrossRefPubMed
5.
Dykes AC, Walker ID, Mc Mahon AD et al (2001) A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol 113:636–641CrossRefPubMed
6.
Beauchamp NJ, Dykes AC, Parikh N et al (2004) The prevalence of, and molecular defects underlying, inherited protein S deficiency in the general population. Br J Haematol 125:647–654CrossRefPubMed
7.
Lane DA, Mannucci PM, Bauer KA et al (1996) Inherited thrombophilia: part 1. Thromb Haemost 76:651–662CrossRefPubMed
8.
Bauduer F, Lacombe D (2005) Factor V Leiden, prothrombin 20210A, methylenetetrahydrofolate reductase 677T, and population genetics. Mol Genet Metab 86:91–99CrossRefPubMed
9.
Kinoshita S, Lida H, Inoue S et al (2005) Protein S and protein C gene mutations in Japanese deep vein thrombosis patients. Clin Biochem 38:908–915CrossRefPubMed
10.
Kim HJ, Seo JY, Lee KO et al (2014) Distinct frequencies and mutation spectrums of genetic thrombophilia in Korea in comparison with other Asian countries both in patients with venous thromboembolism and in general population. Haematologica 99:561–569CrossRefPubMedPubMedCentral
11.
Kimura R, Honda S, Kawasaki T et al (2006) Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients. Blood 107:1737CrossRefPubMed
12.
Zhu T, Ding Q, Bai X et al (2011) Normal ranges and genetic variants of antithrombin, protein C and protein S in the general Chinese population. Results of the Chinese Hemostasis Investigation on Natural Anticoagulants Study I Group. Haematologica 96:1033–1040CrossRefPubMedPubMedCentral
13.
Tang L, Jian XR, Hamasaki N et al (2013) Molecular basis of protein S deficiency in China. Am J Hematol 88:899–905CrossRefPubMed
Metadata
Title
Protein S deficiency in patients from the French Basque Country with various thrombotic conditions: a rarer inherited trait in autochthonous individuals?
Author
Frédéric Bauduer
Publication date
01-08-2018
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 2/2018
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-018-1681-7

Other articles of this Issue 2/2018

Journal of Thrombosis and Thrombolysis 2/2018 Go to the issue

OriginalPaper

Antiphospholipid antibody profile-based outcome of purely vascular and purely obstetric antiphospholipid syndrome

OriginalPaper

Validation of PLASMIC score and follow-up data in a cohort of patients with suspected microangiopathies from Southern Italy

OriginalPaper

Congenital hypodysfibrinogenemia associated with a novel deletion of three residues (γAla289_Asp291del) in fibrinogen

OriginalPaper

Impaired fibrinolysis in degenerative mitral and aortic valve stenosis

OriginalPaper

A pulmonary embolism response team (PERT) approach: initial experience from the Cleveland Clinic

BriefCommunication

Successful treatment with idarucizumab for diffuse alveolar hemorrhage induced by dabigatran etexilate: a case report
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits